|
Logical Biology 9 (2):108-111, 2009 |
HISTORY
RECORDED |
|
http://im1.biz |
|
|
© Truthfinding Cyberpress |
REJECTIONS REVEALED |
Shi V. Liu’s Collection of
Rejections by Mainstream Journals: 2008-2009
Shi
V. Liu
Eagle
Institute of Molecular Medicine
Corresponding
with SVL8EPA@gmail.com
(Received
HIGHLIGHT
A
list of Shi V. Liu’s manuscripts submitted to but either rejected or totally
neglected by some mainstream top journals is published here. From this list, the dark side of some
corrupted journals can be seen more clearly.
ABSTRACT
Over the past two years Shi
V. Liu has submitted more manuscripts to some mainstream top journals. These manuscripts either pointed out the imperfect
repetition of his ground-breaking pioneering discoveries or outright credit
robberies or identified the mistakes in some hot trendy research and even
straight misrepresentations. His
fundamental discoveries on cell life especially the mortal nature for all cell
life showed sharp contrast to some “immortal” views on cell life. His deep insight on cell differentiation and
multicellular development and cancer formation allowed him to easily spot hypes
surrounding the extremely hot iPS research.
However, despite the fact that more and more evidence has come to
validate his points of views, all the mainstream journals except a few such as Biology Direct and Stem Cells and Development have shut their door to Shi V. Liu. Nature
even allowed some direct personal attacks on Liu which resulted in a show down
in a courtroom. The provision of a list
of all the manuscripts that were submitted to but rejected or even
intentionally neglected by various mainstream top journals by Liu in the last
two years gives us an opportunity to seriously examine the current scientific
publishing practice and allows us to realize that some “top” journals are
actually seriously corrupted. Thus, a
revolution in scientific publishing is highly demanded.
KEY WORDS
Discovery,
Repetition, Pioneer, Robbery, Credit, Neglect, Citation, Rejection, Corruption,
Misconduct, Stem cell, iPSCs, Induction, Reprogramming, Misrepresentation,
Hype, Cancer, Publishing, Revolution
Facts speak loud. Thus, I am not going to say anything more
than what has been written into the abstract.
What I need to do is to present titles of manuscripts, along with their
submission dates, journals rejected/neglected them and where they were
published. The published version usually
contains the cover letter to the journals and the rejection notice (if there
was) from the journal. Some also contain
the communications with or the lack of communication from the various “corresponding
authors” of the commented or criticized papers.
The list is arranged
according the chronological order of the submission so that a sequential sense
can be reflected for the development of the related scientific issues.
Table 1. Shi
V. Liu’s 2008-2009 Collection of Rejections by Mainstream Journals.
(Ordered by submission date)
|
No. |
Title |
Submitted (y-m-d) |
Rejected by |
Published in |
|
1 |
One Factor
Dropped from the ‘Inducing’ Soup, One Piece of Evidence Added against the
‘Induction’ Claim |
|
Nature Biotechnology |
LB 8:39 |
|
2 |
IPS Cells Are Man-Made Cancer Cells |
|
Cell |
LB 8:16 |
|
3 |
Are
iPS Cells Really Induced from Differentiated Cells?
|
|
Nature |
LB 8:1 |
|
4 |
Paying
Attention to the Underlying Meaning of Understatements for iPS
Cells |
|
Nature
Biotechnology |
TW 3:12 |
|
5 |
Understanding
the “Reprogramming” Process in “Inducing” iPS Cells |
|
Science |
LB 8:19 |
|
6 |
On the Oct-4 Reporting
Chaos |
|
Cell Stem Cell |
LB 8:25 |
|
7 |
IPS
Cells versus ES Cells |
|
Science |
LB 8:47 |
|
8 |
Can Yamanaka Explain His Contradictory Statements? |
|
Nature |
LB 8:13 |
|
9 |
No More New Complexity Adding to
an Already Simplified Aging Problem |
|
Nature |
LB
8: 8 |
|
10 |
Towards a Balanced View on iPS Cells |
|
Cell Research &
Nature |
LB 8:32 |
|
11 |
A simple experiment to verify the ‘direct reprogramming’ claim on iPS cell ‘induction’ |
|
Nature |
LB
8: 18 |
|
12 |
Revolutionary publishing forms should get credit for enriching science |
|
Nature |
P
3: 1 |
|
13 |
The Final Blow-up of the Induction and
Reprogramming Claim for iPS Cells |
|
Science |
LB 8:57 |
|
14 |
Sequential
Reprogramming of Differentiated Cells into iPS Cells or Sequential
Differentiation of Transformed Pre-existing Stem Cells? |
|
Cell Stem Cell |
LB 8:27 |
|
15 |
Repeated
applications do not validate ‘induction’ of stem cells by iPS
technique |
|
PNAS |
LB 8:30 |
|
16 |
Open the Review Process for
the Public’s Best Interest |
|
Science |
TW 3:4 |
|
17 |
EPA Still Has Many Good
Scientists and Solid Science |
|
Nature |
TW 3:6 |
|
18 |
Allow More Reasoning and Debate in
Scientific Communication |
|
Science |
P
3:3 |
|
19 |
iPS Cells and Pseudoscience:
a Huge Detour in Stem Cell Research |
|
Cell Research |
TW 3:9 |
|
20 |
The
|
|
Nature Biotechnology |
LB 8:62 |
|
21 |
Towards
a Coherent Understanding of Bacterial Aging |
|
PNAS |
TW 3:14 |
|
22 |
On the Rates of Establishing ntESC and the Hope for Improvements |
|
Nature Medicine |
LB 8:51 |
|
23 |
Credit for Critics and a Whole Story for iPS Cells |
|
Nature |
SE 3:6 |
|
24 |
Re-Learn the Polywater
Lesson for iPS Cells |
|
Cell |
TW 3:7 |
|
25 |
Towards a Correct Fundamental
Understanding of Cell Life |
|
Science |
TW 3:16 |
|
26 |
An
April Fool’s Spinning on iPS Cells |
|
Nature |
TW 3:18 |
|
27 |
Evidence for Selection of Pre-existing
Stem Cells Rather than Induction of iPS Cells |
|
Cell |
LB 8:52 |
|
28 |
iPS Confusion and Clarification |
|
Cell Research |
LB 8:56 |
|
29 |
Respecting
a True Pioneer in Clinical Regenerative Medicine |
|
Nature |
P 3:5 |
|
30 |
Towards a Scientific Prediction of
Earthquake |
|
Nature & Science |
TW 3:26 |
|
31 |
Towards a Better
Understanding of Intrinsic Cell Ageing |
|
Nature |
LB 8: 69 |
|
32 |
Denouncing
Martin Ackermann’s Repeated Credit Robberies |
|
BioTechniques |
SE 3: 15 |
|
33 |
Journal Should Press Author for the Truth |
|
Science |
SE 3: 23 |
|
34 |
Recognizing Different Views
in Reviews |
|
Nature |
TW 3:28 |
|
35 |
Applaud a Noble Nobel Prize |
|
Nature |
TW 3:30 |
|
36 |
Multigenic
Cancer Is Distinct from Metastatic Cancer |
|
Science |
IM 3:3 |
|
37 |
Further Clarification Required
after a Nobel Prize |
|
Science |
TW 3:32 |
|
38 |
Eliminating a Highly Misrepresented
Impact Factor |
|
Science |
SE 3: 25 |
|
39 |
Fundamental Mechanism for Intrinsic Ageing |
|
Nature |
TW 3: 34 |
|
40 |
Stop a Nonsense View on Aging |
|
Nature |
LB 8: 77 |
|
41 |
A Fundamentally Flawed Aging Study |
|
PNAS |
LB 8: 79 |
|
42 |
Some
Concerns for Science in |
|
Science |
TW 3: 39 |
|
43 |
On
Objective Measurement of Scientific Impact |
|
PNAS |
TW 3: 41 |
|
44 |
One Step Closer to Confirm a Linkage
between DNA Aging and Cell Aging |
|
Nature |
TW 3: 36 |
|
45 |
Getting
Safer iPS Cells or Reaching an iPS Dead-End? |
|
Science |
LB 8: 82 |
|
46 |
A Fundamentally New
Perspective on the Origin and Evolution of Life |
|
PNAS |
P 3: 7 |
|
47 |
Spending Obama’s “infusion”
money for real changes in science |
|
Science |
P 4: 1 |
|
48 |
An Incomplete and Misguided
Review on Cell Polarity and Differential Inheritance |
|
Cell |
LB 9: 3 |
|
49 |
Toward a Realistic
Re-Assessment of iPSCs |
|
Cell |
LB 9: 7 |
|
50 |
Questions
Regarding iPSC-based Correction of Hemophilia |
|
PNAS |
TW 4:5 |
|
51 |
Open Letter to Cell |
|
Cell |
TW 4:1 |
|
52 |
Are ISCs really
self-renewed? |
|
Nature |
LB 9: 10 |
|
53 |
Plagiarism: Focusing on
Low-Levels but Tolerating High-Levels? |
|
Science |
SE 4:4 |
|
54 |
Reaching a realistic
assessment on iPSCs before developing any Reasonable consent for iPSCs |
|
PLoS Biology |
TW 4:7 |
|
55 |
Embryonic and adult
education on stem cells |
|
Nature |
LB 9: 8 |
|
56 |
Cancer Cell Formation by iPS Techniques: Mechanisms and Testing Approaches |
|
Stem Cells and
Development |
LB 9: 22 |
|
57 |
Are
Generation 2 iPSCs Really Safe? |
|
Nature |
LB 9: 12 |
|
58 |
Still an Incomplete Confirmation
of Some Earlier Discoveries |
|
PNAS |
TW 4:14 |
|
59 |
Distinctions
between iPSCs and ESCs Published Earlier |
|
Nature |
TW 4:18 |
|
60 |
Cancer Risk May Still Present
in Episomally Transformed iPSCs |
|
Science |
LB 9: 14 |
|
61 |
Some Concerns about Protein-Induced Pluripotent
Stem Cells (piPSCs) |
|
Cell
Stem Cell |
LB 9: 16 |
|
62 |
Conflict of Interest:
Declare or Not to Declare? |
|
Nature |
SE 4:7 |
|
63 |
How Could This Happen? |
|
PNAS |
SE 4:1 |
|
64 |
Caution against
Over-Interpreting Niche-Free “Organ” Regeneration from Stem Cells |
|
Nature |
LB 9: 19 |
|
65 |
Tragic History Already
Repeated in Parts in iPSC Research |
|
Science |
TW
4:16 |
|
66 |
Refreshing an Old Look on
iPS Cells |
|
Cell |
TW
4:24 |
|
67 |
How Many Genomes Does
the Giant Bacterium Really Have? |
|
PNAS |
LB 9: 42 |
|
68 |
Distinguishing Cancerous iPSCs from ESCs |
|
PNAS |
TW 4:20 |
|
69 |
Open Public Comments to
Public |
|
Nature |
P 4:13 |
|
70 |
Over-Stretching iPSC Findings May Cause a
Breakage of Public Trust on Science |
|
Nature |
LB 9: 61 |
|
71 |
Published Insights for Distinctions between
iPSCs and ESCs and Why and How |
|
Cell Stem Cell |
LB 9: 44 |
|
72 |
Understanding the Nature and Risk of Incorrectly
Programmed Stem Cells (iPSCs) |
|
Nature Biotechnology |
LB 9: 52 |
|
73 |
Abandon an Empty Stochastic Model and Move
Towards a Deterministic Progress for iPSC Research |
|
Nature |
LB 9: 69 |
|
74 |
iPS Mice: Passing Acid Test
Or Breaking Basic Ethics? |
|
Science |
TW 4:27 |
|
75 |
A Misrepresented Research Finding well
Protected by Nature |
|
Nature |
LB 9: 65 |
|
76 |
Why Do We Need “Fully Pluripotent” iPS Cells? |
|
Nature |
TW 4:29 |
|
77 |
Reasons for And Cautions
against Near-Final Version Publications |
|
Nature |
TW 4:31 |
|
78 |
Alternative Views on a Recent PNAS iPSC
Publication and Further Suggestions |
|
PNAS |
LB 9: 77 |
|
79 |
Medical and Ethical Concerns over Using Safety-Unproven iPSCs for |
|
Cell Research |
SE 4:9 |
|
80 |
"Induced" Eyes Might Have Captured
Some Truth on Development |
|
PLoS Biol |
LB 9: 79 |
|
81 |
Your Data but My Finding:
What Is Science? |
|
Science |
SE 4:21 |
|
82 |
Solid Observations Fraught with Erroneous Interpretations and Wrong
Conclusions |
|
Nature |
LB 9: 92 |
|
83 |
Outright Misrepresentation Should Be an Easy
Target Amenable to Invalidation |
|
Nature |
LB 9: 97 |
|
84 |
Reproduction, Reproduction,
Reproduction |
|
Science |
TW 4:42 |
|
85 |
Fast Protest against a Fast
Hype on iPS Cells |
|
Nature |
TW 4:47 |
*
Abbreviations for new-generation journals. LB
= Logical Biology, SE = Scientific
Ethics, P = Pioneer, TW = Top Watch, IM = International Medicine. All of these journals can be found at http://im1.biz